All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $30,000.00 income · posted Jan 16, 2026

Official filing document

Bills named in this filing 3

HR 1990
American Innovation and R&D Competitiveness Act of 2025
S 1649
Sporting Goods Excise Tax Modernization Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.